"Iowa Diabetes Research's mission is to improve the health and lives of Iowans affected by diabetes. We achieve this by advancing research on diabetes treatment options and by educating patients on how to better manage their diabetes."

During the past decade, Iowa Diabetes and Endocrinology Research Center conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 15 clinical trials were completed, i.e. on average, 39.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 12 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iowa Diabetes and Endocrinology Research Center" #1 sponsor was "Eli Lilly and Company" with 18 trials, followed by "Medtronic Diabetes" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "DexCom, Inc." with 3 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Diabetes and Endocrinology Research Center" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Jaeb Center for Health Research" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Iowa Diabetes and Endocrinology Research Center" are "Type 2 Diabetes" (9 trials), "Diabetes Mellitus, Type 2" (7 trials), "Diabetes Mellitus, Type 1" (5 trials), "Type 1 Diabetes" (5 trials) and "Type 1 Diabetes Mellitus" (4 trials). Many other conditions were trialed in "Iowa Diabetes and Endocrinology Research Center" in a lesser frequency.

Most popular intervention types in "Iowa Diabetes and Endocrinology Research Center" are "Drug" (29 trials), "Device" (11 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Tirzepatide" (9 trials), "Insulin Degludec" (8 trials), "Dulaglutide" (3 trials) and "Insulin Efsitora Alfa" (3 trials). Other intervention names were less common.

The vast majority of trials in "Iowa Diabetes and Endocrinology Research Center" are 43 trials for "All" genders.

Currently, there are NaN active trials in "Iowa Diabetes and Endocrinology Research Center". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Iowa Diabetes and Endocrinology Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Iowa Diabetes and Endocrinology Research Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".